The AI Economy Reshapes Employment BlueCollar Workers Gain Ground as College Graduates Face Headwinds April Jobs Report Expected to Show Cooling Yet Resilient Labor Market Tourism Imbalance Turkish Visitors Surge to Greece as Greek Tourists Shun Turkey Wall Street Eyes 16 Trillion Valuation for AI Giant but Historical Patterns Raise Caution China Calls for APEC Cooperation as Commerce Minister Skips Opening Meeting Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office Everest Group Q1 2026 Earnings Strong EPS Beat Highlights Underwriting Strength MACOM Technology Solutions MTSI Q1 2026 Earnings EPS Slightly Misses Estimates as Shares Edge Lower NMRK Q1 2026 Earnings EPS Surpasses Estimates by 18 Stock Unchanged Polaris PII Q1 2026 Earnings Significant EPS Beat Drives Positive Market Reaction GYRE Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Surprise Amid Revenue Absence MNRO Q1 2026 Earnings EPS Surpasses Estimates as Cost Management Drives Profitability Natuzzi SpA NTZ Holds Steady at 255 as Traders Eye Resistance Ascent Solar Technologies ASTI Surges 12 as Momentum Builds Above Key Support Inuvo Inc INUV Edges Higher as Price Stabilizes Near Key Support Cingulate Inc CING Plunges 17 as Selling Pressure Intensifies Ategrity Specialty Insurance ASIC Edges Higher Approaching Resistance AI Economy Reshapes Job Market BlueCollar Workers May Benefit as College Graduate Hiring Slows SCCF Q4 2025 Earnings Massive EPS Surprise of 782 Driven by Strong Operational Performance CareCloud CCLD Gains 356 as Investor Sentiment Improves Key Resistance Level in Focus PhenixFIN Notes PFXNZ Edge Higher Near Resistance Amid Subdued Trading Esperion Therapeutics ESPR Holds Steady Amid Key Support and Resistance Levels Shoulder Innovations Inc SI Consolidates Near Key Support Level After Flat Trading Day ASGN Incorporated ASGN Plunges 5169 Key Levels and What Lies Ahead CCH Holdings CCHH Sheds 8 as Stock Approaches Key Support at 044 Array Digital Infrastructure AD Holds Steady Near Support as Consolidation Continues Stoke Therapeutics STOK Sees Minor Decline as Shares Test Support Near 28 Level